Biogen CEO Scangos departing

Biogen Inc. (NASDAQ:BIIB) gained $20.04 to $282.45 on Thursday after disclosing strong 2Q16 financial results and saying CEO George Scangos will depart "in the coming months" after the company identifies a successor. Biogen said Scangos plans to return to the West Coast, "take on one more set of activities," and spend time with family.

Scangos, 68, said on a conference call Thursday he will work with Biogen's board to find his successor, and said the company will consider internal and external candidates. ...